Published On: August 12th, 2020Categories: Patent Applications, Patents

With the ongoing pandemic and the imposed rules for physical distancing, remote patient monitoring (RPM) and remote diagnostics are becoming increasingly relevant. Companies are now developing products and software applications for COVID-19 screening, risk assessments, digital therapeutics, and remote patient monitoring systems. The current pandemic is also accelerating changes in the practice of medicine, spurring innovations around technologies that allow patients to interact with the healthcare system virtually.

We cover some of the latest happenings around remote patient monitoring (RPM) and remote diagnostics below.

FDA Issues Guidance Expanding the Availability and Capability of Non-Invasive Remote Monitoring Devices

The FDA has issued Emergency Use Authorizations (EUA) for certain remote or wearable patient monitoring devices to help increase the availability of patient monitoring and the reduction of healthcare provider exposure to SARS-CoV-2. The FDA has also recently issued several guidelines related to the use of non-invasive monitoring devices. Some of the devices that recently received EUA approval include a Remote Patient QT Interval Monitor (such as VSMS ECG Patch), a Nurse Call System (ex. Ascom teleCARE IP Nurse Call System), and a Patient Isolation Transport Unit (PITU).

Withings Turns Its Focus to Remote Patient Monitoring

With $60M in new funding, Paris-based Withings plans to carve out a new strategy for its connected health devices. Withings is moving away from the consumer segment to medical professionals following its split from Nokia in 2018. Withings MED PRO, the business-to-business division of the firm is building a dashboard for physicians to help them track patient metrics, such as blood pressure, as well as receive reimbursements. To read more, click here.

Philips and BioIntelliSense Integrate to Enhance Remote Patient Monitoring

Philips integrates the FDA-cleared BioSticker™ sensor from BioIntelliSense as part of its remote monitoring solutions for patients outside the hospital. BioSticker is a single-use, FDA-cleared 510k class II wearable medical device designed to enable at-home continuous, passive monitoring with minute level data across a broad set of vital signs, physiological biometrics and symptomatic events. To read more, click here.

BioTelemetry Inc. Acquires On.Demand™, a Remote Patient Monitoring (RPM) Platform

BioTelemetry, a leader in remote medical technology announced that it has acquired On.Demand™, an RPM and coaching platform. On.Demand is an mHealth solution that combines real-time monitoring of biometric data with cellular- and web-based technology, health coaching, and population health reporting. The acquisition comes at a time when remote and telehealth options are increasingly important in improving effectiveness across the healthcare continuum. To read more, click here.

Huma Teams Up With Cambridge University For a Remote Patient COVID-19 Study

Digital health specialist Huma has announced its support for a crucial research product at the University of Cambridge, which aims to improve early detection of Covid-19 infections. Huma’s RPM technology will be used to collect data from thousands of participants taking part in the University of Cambridge’s study, which aims to better understand the early signs and progression of the virus. To read more, click here.

Nanowear Announces a Remote Diagnostic Research Collaboration with New York City-Metro Health Systems

Nanowear, a nanotechnology-based connected-care and remote diagnostic platform, recently announced an expanded COVID-19 remote diagnostic research alliance with Hackensack Meridian Health Systems. The clinical trial collaboration focuses on utilizing remote diagnostic monitoring through the use of cloth-based wearable technology. To read more, click here.

Israel Tests Military Radar to Examine Coronavirus Patients Remotely

Elbit Systems and Elta Systems, two Israeli companies are trying out a new system that uses existing military radar technology to examine coronavirus patients without coming into physical contact with them. To read more, click here.

Proscia® Offers Its Digital Pathology Software for Remote Use

Concentriq Dx, is a digital pathology software product for use in securely reviewing and reporting digital pathology slides, thus enabling pathologists to read cases from remote locations, including home offices, by using an internet browser. To read more, click here.

Medicspot Rolls Out Remote Diagnostics System Amid COVID19

Medicspot is rolling out a health diagnosis system across the UK that allows general practitioners (GPs) to assess patients remotely. Medicspot is installed at accessible locations and allows doctors to see patients remotely and carry out tests including temperature, oxygen levels and heart and lung checks. This self-service station guides the patient on performing an examination on themselves whilst the doctor is there to ensure that the patient is doing it correctly. To read more, click here.

Interested to know more? Check out our earlier post on telemedicine here or watch our on-demand webinar on activity trackers.

To learn more about MaxVal’s Search and Analytics services, click here.


Have any content requests?

You can let us know at [email protected]

Get the latest IP data, insights and inspiration directly delivered to your inbox